tPA for Stroke : The Story of a Controversial Drug

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.
Interesting topic! Thank you for bringing this up after all these topics of "neurology or psychology" and INR pathways" and etc.

it is always both sides for a story and there are some pros and cons for every medicine, even multi-vitamins. I think tPA is now the only medicine that we have for stroke and there are new data coming out that it might help restore neurons in mice intra-nasally even 10-14 days after stroke. That is super interesting.

http://www.ncbi.nlm.nih.gov/pubmed/22115941

also there is some data that it might be toxic and cause neuron death.\

http://www.ncbi.nlm.nih.gov/pubmed/21998719


There are newer thrombolytics under way, like Tenectaplase that they use for Acute MI but we have given that for stroke and it has worked. Actually the phase 2 of study on Tenectalplace (TNK) was held because of poor recruitment.

http://www.ncbi.nlm.nih.gov/pubmed/21737464

http://www.ncbi.nlm.nih.gov/pubmed/22111795


I think at this time, it works well for our purpose when we do not have anything else to offer (for someone that do not have access to mechanical thrombctomy or does have small vessles thrombus that won't worth going after it) it gives me a self-satisfaction that at least I do something for patients, especially when they arrive in the first hour after stroke. I believe, it really works if it is given early (less than 2 hours) and studies support that.

http://stroke.ahajournals.org/content/40/6/2268.full.pdf
 
Top